Combination of Alarm-intervention and Reboxetine in Therapy- Resistant Enuresis

Authors

  • Kirill Kosilov Professor of Department of Social Sciences, School of Humanities, Far Eastern Federal University, and Professor of Department of Fundamental Medicine, School of Biomedicine, Far Eastern Federal University
  • Irina Kuzina Head of the Department of Social Science, Far Eastern Federal University
  • Yuliya Gainullina Professor of Department of Social Sciences, School of Humanities, Far Eastern Federal University
  • Vladimir Kuznetsov Head of Department of Public Health of the Pacific State Medical University
  • Liliya Kosilova Doctor in the Department of Functional Diagnostics
  • Elena Viktorovna Karashchuk Department of Public Health, Pacific Medical University
  • Alexandra Prokofyeva Leading specialist of the Department of Social Sciences Far Eastern Federal University
  • Sergay Loparev Department of Urology, City polyclinic No 3

DOI:

https://doi.org/10.3126/jnps.v37i3.18120

Keywords:

Alarm intervention, Children and adolescents, Reboxetine

Abstract

Introduction: The first-line treatments of primary monosymptomatic night enuresis (PMNE) are alarm intervention and desmopressin. Some patients are resistant to these modes of treatment. Therefore Reboxetine has been used to treat PMNE in these scenarios in recent years and published in many studies. The aim of the study was to determine effectiveness and safety of combination of Alarm intervention and Reboxetine, to treat patients with therapyresistant enuresis.

Material and Methods: Two hundred and nineteen children of both sexes were participated in the experiment (average age, 11.3 years). Participants were divided into three groups: Group A (71 patients, Alarm intervention), Group B (79 patients, Reboxetine as monotherapy), Group C (69 patients, Alarm intervention + Reboxetine). The duration of treatment was twelve weeks, followed by follow-up period of twelve weeks to see efficacy.

Result: There was no significant change in number of enuresis episodes per week before and after treatment in a group B. The number of enuresis episodes per a week (weekly) in a group C reached: before treatment 5.3 (1.5), after treatment 1.0 (0.8), 3 three months after the end of treatment 0.7 (0.7). The percentage of patients with PMNE in a group C was significantly less immediately after the course of treatment (17.4%), and three months after treatment (24.6%).

Conclusion: Combined treatment of therapy-resistant enuresis with use of Alarm Intervention and Reboxetine gives a high percentage of cured patients both immediately after therapy (82.6%) and three months after the end (75.4%).

Downloads

Download data is not yet available.
Abstract
921
PDF
631

Downloads

Published

2018-06-07

How to Cite

Kosilov, K., Kuzina, I., Gainullina, Y., Kuznetsov, V., Kosilova, L., Karashchuk, E. V., Prokofyeva, A., & Loparev, S. (2018). Combination of Alarm-intervention and Reboxetine in Therapy- Resistant Enuresis. Journal of Nepal Paediatric Society, 37(3), 213–219. https://doi.org/10.3126/jnps.v37i3.18120

Issue

Vol. 37 No. 3 (2017)

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).